We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AMZN:NASDAQAmazon.com, Inc. Analysis

Data as of 2026-05-18 - not real-time

$265.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Amazon delivered a Q1 2026 revenue increase of 16.6% to $181.5 B and GAAP EPS of $2.78, beating expectations by 68%, while raising its next‑quarter revenue guidance to $196.5 B – a 4% premium to analyst forecasts. The stock is trading at $265.59, comfortably above the 20‑day SMA ($265.39) and the longer‑term SMAs (50‑day $237.76, 200‑day $229.57), underscoring a bullish price trend despite a bearish MACD histogram and decreasing volume. Technical momentum is tempered by an RSI of 60 and a high beta of ~1.43, indicating elevated volatility (30‑day ~26%). Fundamentals remain strong with a 12.2% profit margin, ROE of 24%, and robust cash flow, though the balance sheet shows a debt‑to‑equity of 53% and net debt exceeding cash. Analyst consensus is a “strong buy” with a median target of $317, implying roughly 17% upside from current levels, and the market sentiment is in “Extreme Greed” territory. Overall, the blend of earnings beat, solid growth outlook, and favorable analyst targets supports a positive outlook, but the high volatility and leverage suggest caution on the short‑term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with bearish MACD signal
  • Decreasing volume trend
  • Strong earnings beat but short‑term pull‑back risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue guidance above expectations
  • Analyst median target price $317 (+17% upside)
  • Continued AWS and supply‑chain service expansion

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained high operating margins and cash generation
  • Strategic diversification across retail, cloud, and logistics
  • Strong brand moat and market‑share leadership

Key Metrics & Analysis

Financial Health

Revenue Growth16.60%
Profit Margin12.22%
P/E Ratio31.8
ROE24.29%
ROA6.84%
Debt/Equity53.30
P/B Ratio6.5
Op. Cash Flow$148.5B
Free Cash Flow$9.8B

Technical Analysis

TrendBullish
RSI60.0
Support$249.10
Resistance$278.56
MA 20$265.39
MA 50$237.76
MA 200$229.57
MACDBearish
VolumeDecreasing
Fear & Greed Index88.2

Valuation

Fair Value$15.32
Target Price$311.55
Upside/Downside17.31%
GradeFair
TypeGrowth

Risk Assessment

Beta1.43
Volatility26.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.